JP2022509358A5 - - Google Patents
Info
- Publication number
- JP2022509358A5 JP2022509358A5 JP2021547654A JP2021547654A JP2022509358A5 JP 2022509358 A5 JP2022509358 A5 JP 2022509358A5 JP 2021547654 A JP2021547654 A JP 2021547654A JP 2021547654 A JP2021547654 A JP 2021547654A JP 2022509358 A5 JP2022509358 A5 JP 2022509358A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxypropyl
- cyclodextrin
- composition
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862752131P | 2018-10-29 | 2018-10-29 | |
| US62/752,131 | 2018-10-29 | ||
| US201962885053P | 2019-08-09 | 2019-08-09 | |
| US62/885,053 | 2019-08-09 | ||
| PCT/US2019/057784 WO2020092107A1 (en) | 2018-10-29 | 2019-10-24 | Methods for treating alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022509358A JP2022509358A (ja) | 2022-01-20 |
| JP2022509358A5 true JP2022509358A5 (https=) | 2022-10-28 |
| JP7446322B2 JP7446322B2 (ja) | 2024-03-08 |
Family
ID=68583503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547654A Active JP7446322B2 (ja) | 2018-10-29 | 2019-10-24 | アルツハイマー病を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11925659B2 (https=) |
| EP (1) | EP3873604B1 (https=) |
| JP (1) | JP7446322B2 (https=) |
| KR (1) | KR20210084480A (https=) |
| CN (1) | CN112996562A (https=) |
| BR (1) | BR112021008139A2 (https=) |
| CA (1) | CA3114021C (https=) |
| ES (1) | ES2992137T3 (https=) |
| PT (1) | PT3873604T (https=) |
| WO (1) | WO2020092107A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| US11466008B2 (en) | 2017-09-18 | 2022-10-11 | Eip Pharma, Llc | Co-crystals of neflamapimod (VX-745) |
| CN113490691A (zh) | 2019-01-03 | 2021-10-08 | 劣势者药物有限公司 | 环糊精二聚体、其组合物及其用途 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
| EP4157290A4 (en) * | 2020-06-02 | 2024-06-05 | National University of Singapore | COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREFOR |
| WO2022051631A1 (en) | 2020-09-03 | 2022-03-10 | University Of Notre Dame Du Lac | Therapy to stimulate hippocampal neural progenitors and adult neurogenesis |
| WO2022099094A1 (en) * | 2020-11-06 | 2022-05-12 | Eip Pharma, Inc. | Compositions and methods for treating depression |
| EP4240486A4 (en) * | 2020-11-06 | 2024-05-22 | EIP Pharma, Inc. | TREATMENT OF GALKING DYSFUNCTION IN THE CONTEXT OF A NEURODEGENERATIVE DISEASE |
| US12285440B2 (en) | 2021-03-14 | 2025-04-29 | Massachusetts Institute Of Technology | APOE4 impairs myelination via altered cholesterol biosynthesis and transport in oligodendroglia |
| WO2023089062A1 (en) * | 2021-11-18 | 2023-05-25 | Vib Vzw | Improved gamma-secretase inhibitor screening assays |
| WO2023156966A1 (en) | 2022-02-18 | 2023-08-24 | Beren Therapeutics P.B.C. | Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same |
| WO2023191425A1 (ko) * | 2022-03-28 | 2023-10-05 | 주식회사 비엔에이치리서치 | 약물의 전기생리학적 스크리닝 방법 |
| CN114569742B (zh) * | 2022-05-09 | 2022-07-19 | 北京剂泰医药科技有限公司 | 一种组合物及其制备方法和应用 |
| CA3259307A1 (en) * | 2022-06-13 | 2023-12-21 | Beren Therapeutics P.B.C. | SYSTEMS AND METHODS FOR MANUFACTURING HYDROXYPROPYL-BETA-CYCLODEXTRIN |
| EP4561566A1 (en) * | 2022-07-29 | 2025-06-04 | Anavex Life Sciences Corp. | Compositions and methods for prevention of cognitive decline caused by degenerative diseases |
| KR20250073473A (ko) * | 2022-09-30 | 2025-05-27 | 싸이클로 테라퓨틱스, 아이엔씨. | 조기 알츠하이머병 치료 방법 |
| WO2025214478A1 (zh) * | 2024-04-12 | 2025-10-16 | 北京华昊中天生物医药股份有限公司 | 一种优替德隆药物组合物及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3346123A1 (de) | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
| US4877778A (en) | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| US5569756A (en) | 1995-03-21 | 1996-10-29 | American Maize-Products Company | Purification of chemically modified cyclodextrins |
| US8883494B2 (en) | 2003-11-14 | 2014-11-11 | Adil A. KHAN | In vitro model for neuronal death |
| CN101674842A (zh) | 2007-03-02 | 2010-03-17 | 普瑞芬医药有限公司 | 治疗阿尔茨海默氏病和痴呆的组合物和方法 |
| MX371073B (es) | 2012-04-13 | 2020-01-15 | L&F Res Llc | Método para utilizar ciclodextrina. |
| CN107865968B (zh) | 2012-08-03 | 2021-03-05 | 美国政府(由卫生和人类服务部的部长所代表) | 用于治疗溶酶体贮积症的环糊精 |
| FR3014694B1 (fr) | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| US10413517B2 (en) | 2014-06-12 | 2019-09-17 | University Of Notre Dame Du Lac | Composition and method for the treatment of neurological diseases and cerebral injury |
| WO2016168772A1 (en) | 2015-04-17 | 2016-10-20 | Sens Research Foundation, Inc. | Cyclodextrin compounds for the prevention and treatment of aging |
| JP2018517046A (ja) | 2015-06-10 | 2018-06-28 | ビテス， インコーポレイテッド | ヒドロキシプロピル−ベータ−シクロデキストリン組成物および方法 |
| US20200000840A1 (en) * | 2016-03-20 | 2020-01-02 | Asdera Llc | Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders |
-
2019
- 2019-10-24 BR BR112021008139-9A patent/BR112021008139A2/pt unknown
- 2019-10-24 PT PT198054397T patent/PT3873604T/pt unknown
- 2019-10-24 ES ES19805439T patent/ES2992137T3/es active Active
- 2019-10-24 CN CN201980071651.0A patent/CN112996562A/zh active Pending
- 2019-10-24 JP JP2021547654A patent/JP7446322B2/ja active Active
- 2019-10-24 CA CA3114021A patent/CA3114021C/en active Active
- 2019-10-24 KR KR1020217013055A patent/KR20210084480A/ko not_active Ceased
- 2019-10-24 US US17/289,137 patent/US11925659B2/en active Active
- 2019-10-24 WO PCT/US2019/057784 patent/WO2020092107A1/en not_active Ceased
- 2019-10-24 EP EP19805439.7A patent/EP3873604B1/en active Active
-
2024
- 2024-01-29 US US18/425,707 patent/US20240415871A1/en not_active Abandoned
-
2025
- 2025-06-09 US US19/232,726 patent/US20250302864A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022509358A5 (https=) | ||
| CN111065411B (zh) | Pd-1抗体和vegfr抑制剂联合治疗小细胞肺癌的用途 | |
| AU2012321110B2 (en) | Combination treatment | |
| JP2019530713A5 (https=) | ||
| CN104684579A (zh) | 单特异性的和双特异性的抗-IGF-1R 和抗-ErbB3 抗体的剂量和施用 | |
| Tanasescu et al. | Advances in the treatment of relapsing-remitting multiple sclerosis | |
| JP2015510908A (ja) | 増殖性疾患の治療のための併用療法（ベムラフェニブ及びｍｄｍ２阻害剤） | |
| JP2017537105A5 (https=) | ||
| JP2013527132A (ja) | 中枢神経系（ｃｎｓ）の自己免疫性脱髄性疾患の治療において使用するためのジアゾキシド | |
| JP7217789B2 (ja) | 併存疾患としてアパシーを伴うアルツハイマー病の治療における使用のための５－ｈｔ６受容体アンタゴニスト | |
| JP2015172060A5 (https=) | ||
| Rossignol et al. | Evolution and treatment of childhood chronic inflammatory polyneuropathy | |
| Serratosa et al. | Safety and tolerability of perampanel: a review of clinical trial data | |
| IL292706A (en) | Type i interferon inhibition in systemic lupus erythematosus | |
| JP2020517671A5 (https=) | ||
| JP2019507786A5 (https=) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| CN112955148B (zh) | Cdk4/6抑制剂联合免疫治疗在制备治疗淋巴瘤的药物中的用途 | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| CN120826242A (zh) | 抗cd20抗体药物偶联物在制备治疗套细胞淋巴瘤的药物中的用途 | |
| JP2005529152A5 (https=) | ||
| KR20240046527A (ko) | 암치료를 위한 신규 경구용 약학적 조성물 | |
| TWI726355B (zh) | 苯甲酸或其鹽及衍生物用於預防或治療抗n-甲基-d-天冬胺酸受體腦炎之用途 | |
| JP2020172471A (ja) | ヒト化抗ヒトｃｄ２６抗体を含有する医薬組成物 | |
| Bronson et al. | Το Market, Το Market-2012 |